Essential properties of drug-targeting delivery systems
- PMID: 16376827
- DOI: 10.1016/S1359-6446(05)03698-6
Essential properties of drug-targeting delivery systems
Abstract
How, if at all, can drug delivery help to create ideal drugs? After four decades of trying, an effective site-specific drug-delivery system has not yet been developed. This review draws attention to the pharmacokinetic conditions that must be met to achieve a successful performance by site-selective drug-carrier delivery systems. In a drug-carrier approach, a drug is attached to a macromolecular carrier via a chemically labile linker. The carrier transports the drug to its site of action and releases it at the target site. For this simple approach to work, several fundamental conditions (nonspecific interactions, target site access, drug release and drug suitability) must be satisfied. The importance of these essential requirements, not always recognized in the development of drug-delivery systems, is discussed and illustrated by recent examples selected from the literature.
Similar articles
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Tumour-targeted drug and gene delivery: principles and concepts.Expert Rev Mol Med. 2004 Sep 13;6(19):1-17. doi: 10.1017/S1462399404008269. Expert Rev Mol Med. 2004. PMID: 15387893 Review.
-
[Drug delivery systems using nano-sized drug carriers].Gan To Kagaku Ryoho. 2005 Jul;32(7):935-40. Gan To Kagaku Ryoho. 2005. PMID: 16044950 Review. Japanese.
-
Bone-targeting macromolecular therapeutics.Adv Drug Deliv Rev. 2005 May 25;57(7):1049-76. doi: 10.1016/j.addr.2004.12.011. Epub 2005 Apr 15. Adv Drug Deliv Rev. 2005. PMID: 15876403 Review.
-
Role of polyanhydrides as localized drug carriers.J Control Release. 2005 Apr 18;103(3):541-63. doi: 10.1016/j.jconrel.2004.12.021. J Control Release. 2005. PMID: 15820403 Review.
Cited by
-
Novel cyclic phosphate prodrug approach for cytochrome P450-activated drugs containing an alcohol functionality.Pharm Res. 2007 Apr;24(4):679-87. doi: 10.1007/s11095-006-9187-y. Epub 2007 Feb 15. Pharm Res. 2007. PMID: 17372695
-
Targeted Therapy for Glomerulonephritis Using Arterial Delivery of Encapsulated Etanercept.Int J Mol Sci. 2023 Feb 1;24(3):2784. doi: 10.3390/ijms24032784. Int J Mol Sci. 2023. PMID: 36769101 Free PMC article.
-
Laponite-Based Nanomaterials for Drug Delivery.Adv Healthc Mater. 2022 Apr;11(7):e2102054. doi: 10.1002/adhm.202102054. Epub 2022 Feb 4. Adv Healthc Mater. 2022. PMID: 34990081 Free PMC article. Review.
-
Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles.Int J Nanomedicine. 2019 May 8;14:3389-3401. doi: 10.2147/IJN.S198848. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31190798 Free PMC article. Review.
-
Electromotive Enhanced Drug Administration in Oncology: Principles, Evidence, Current and Emerging Applications.Cancers (Basel). 2022 Oct 11;14(20):4980. doi: 10.3390/cancers14204980. Cancers (Basel). 2022. PMID: 36291762 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous